Societe Des Produits Nestle S.a. - Net Worth and Insider Trading
Societe Des Produits Nestle S.a. Net Worth
The estimated net worth of Societe Des Produits Nestle S.a. is at least $2.7 Billion dollars as of 2024-12-27. Societe Des Produits Nestle S.a. is the 10% Owner of Aimmune Therapeutics Inc and owns about 79,571,513 shares of Aimmune Therapeutics Inc (AIMT) stock worth over $2.7 Billion. Societe Des Produits Nestle S.a. is also the 10% Owner of Axcella Health Inc and owns about 444,218 shares of Axcella Health Inc (AXLA) stock worth over $178,087. Details can be seen in Societe Des Produits Nestle S.a.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Societe Des Produits Nestle S.a. has not made any transactions after 2022-10-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Societe Des Produits Nestle S.a.
Societe Des Produits Nestle S.a. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Societe Des Produits Nestle S.a. owns 3 companies in total, including Aimmune Therapeutics Inc (AIMT) , Axcella Health Inc (AXLA) , and Prometheus Biosciences Inc (RXDX) .
Insider Ownership Summary of Societe Des Produits Nestle S.a.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AIMT | Aimmune Therapeutics Inc | 2020-10-13 | 10 percent owner |
| AXLA | Axcella Health Inc | 2022-10-13 | 10 percent owner |
| RXDX | Prometheus Biosciences Inc | 2021-03-11 | 10 percent owner |
Societe Des Produits Nestle S.a. Latest Holdings Summary
Societe Des Produits Nestle S.a. currently owns a total of 2 stocks. Among these stocks, Societe Des Produits Nestle S.a. owns 79,571,513 shares of Aimmune Therapeutics Inc (AIMT) as of October 13, 2020, with a value of $2.7 Billion and a weighting of 99.99%. Societe Des Produits Nestle S.a. also owns 444,218 shares of Axcella Health Inc (AXLA) as of October 13, 2022, with a value of $178,087 and a weighting of 0.01%.
Latest Holdings of Societe Des Produits Nestle S.a.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AIMT | Aimmune Therapeutics Inc | 2020-10-13 | 79,571,513 | 34.49 | 2,744,421,483 |
| AXLA | Axcella Health Inc | 2022-10-13 | 444,218 | 0.40 | 178,087 |
Holding Weightings of Societe Des Produits Nestle S.a.
Societe Des Produits Nestle S.a. Form 4 Trading Tracker
According to the SEC Form 4 filings, Societe Des Produits Nestle S.a. has made a total of 2 transactions in Aimmune Therapeutics Inc (AIMT) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Aimmune Therapeutics Inc is the acquisition of 54,117,287 shares on October 13, 2020, which cost Societe Des Produits Nestle S.a. around $1.9 Billion.
According to the SEC Form 4 filings, Societe Des Produits Nestle S.a. has made a total of 2 transactions in Axcella Health Inc (AXLA) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Axcella Health Inc is the acquisition of 146,341 shares on October 13, 2022, which cost Societe Des Produits Nestle S.a. around $6 Million.
Insider Trading History of Societe Des Produits Nestle S.a.
- 1
Societe Des Produits Nestle S.a. Trading Performance
GuruFocus tracks the stock performance after each of Societe Des Produits Nestle S.a.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Societe Des Produits Nestle S.a. is -31.9%. GuruFocus also compares Societe Des Produits Nestle S.a.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Societe Des Produits Nestle S.a. within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Societe Des Produits Nestle S.a.'s insider trading performs compared to the benchmark.
Performance of Societe Des Produits Nestle S.a.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -24.11 | | | | | |
| Relative Return to S&P 500(%) | -23.75 | | | | | |
Societe Des Produits Nestle S.a. Ownership Network
Societe Des Produits Nestle S.a. Owned Company Details
What does Aimmune Therapeutics Inc do?
Who are the key executives at Aimmune Therapeutics Inc?
Societe Des Produits Nestle S.a. is the 10 percent owner of Aimmune Therapeutics Inc. Other key executives at Aimmune Therapeutics Inc include Chief Financial Officer Eric Bjerkholt , Chief Medical Officer Adelman Daniel C Md , and See Remarks Douglas T. Sheehy .
Aimmune Therapeutics Inc (AIMT) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Aimmune Therapeutics Inc (AIMT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aimmune Therapeutics Inc (AIMT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Aimmune Therapeutics Inc (AIMT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aimmune Therapeutics Inc Insider Transactions
Societe Des Produits Nestle S.a. Mailing Address
Above is the net worth, insider trading, and ownership report for Societe Des Produits Nestle S.a.. You might contact Societe Des Produits Nestle S.a. via mailing address: Avenue Nestle 55, Vevey V8 Ch-1800.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
